Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response. [PDF]
Kalkowska DA +4 more
europepmc +1 more source
A Health Economic Analysis for Oral Poliovirus Vaccine to Prevent COVID-19 in the United States. [PDF]
Thompson KM +2 more
europepmc +1 more source
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China. [PDF]
Tang X +17 more
europepmc +1 more source
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials. [PDF]
Gast C +19 more
europepmc +1 more source
Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns. [PDF]
Godin A +15 more
europepmc +1 more source
Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak - Tajikistan, 2020-2021. [PDF]
O'Connor P +6 more
europepmc +1 more source
Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine. [PDF]
Konz JO +15 more
europepmc +1 more source
According to manufacturers, inactivated poliovirus vaccines (IPVs) are freeze sensitive and require storage between 2\ub0C and 8\ub0C, whereas oral poliovirus vaccine requires storage at -20\u202f\ub0C.
core

